Indivior PLC Ordinary Shares (INDV) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Over the past 2 years, Indivior PLC Ordinary Shares has achieved a revenue compound annual growth rate (CAGR) of 14.8%.
Historical revenue and profitability trends for Indivior PLC Ordinary Shares
The chart above illustrates Indivior PLC Ordinary Shares's revenue trajectory over the past 2 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Indivior PLC Ordinary Shares's business.
How efficiently Indivior PLC Ordinary Shares converts revenue into profit
Profit margins reveal how much of each dollar of revenue Indivior PLC Ordinary Shares retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Indivior PLC Ordinary Shares to continue growing earnings in the coming year. The consensus analyst rating is 4.7143 based on 7 analysts.
Based on our comprehensive analysis, Indivior PLC Ordinary Shares (INDV) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Indivior PLC Ordinary Shares's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Indivior PLC Ordinary Shares stacks up against similar companies
Explore growth analysis for top stocks
Related: INDV Valuation, INDV Dividend, INDV Financial Health
Compare: INDV vs AAPL, INDV vs MSFT, INDV vs GOOGL